Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Subtilisins" patented technology

A family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.-

Double stranded rnai agents, compositions and methods of use

PCT designated stageWO2026110119A1PeptidasesDNA/RNA fragmentationProprotein Convertase Subtilisin/Kexin 9Subtilisins
Disclosed are, inter alia, double stranded RNAi (dsRNAi) agents inhibiting expression of proprotein convertase subtilisin kexin 9 (PCSK9), for example, human PCSK9, compositions including the same, and methods of treatment using the same.
Owner:NOVARTIS AG

Combinations of antisense agents, pharmaceutical compositions and methods of use

PCT designated stageWO2026133250A1DNA/RNA fragmentationProprotein Convertase Subtilisin/Kexin 9Pharmaceutical drug
Disclosed are, inter alia, combinations comprising a first antisense (e.g., first double stranded RNAi (dsRNAi)) agent for inhibiting expression of proprotein convertase subtilisin kexin 9 (PCSK9), for example, human PCSK9, and a second antisense agent (e.g., second dsRNAi agent) for inhibiting expression of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR); pharmaceutical compositions including the same, and methods of treatment using the same.
Owner:NOVARTIS AG

DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE

PendingUS20260146251A1PeptidasesDNA/RNA fragmentationProprotein Convertase Subtilisin/Kexin 9Subtilisins
Disclosed are, inter alia, double stranded RNAi (dsRNAi) agents inhibiting expression of proprotein convertase subtilisin kexin 9 (PCSK9), for example, human PCSK9, compositions including the same, and methods of treatment using the same.
Owner:NOVARTIS AG

Compositions and methods comprising variant microbial proteases

The present invention provides variant subtilisins and compositions comprising at least one variant subtilisin set forth herein, as well as methods for using these variants and compositions. In some embodiments, the present invention provides variant subtilisins suitable for laundry cleaning applications.
Owner:DANISCO US INC

A preparation for pet oral cleaning, softening dental plaque and calculus and its preparation method

PendingCN122272461ABiologyAntibacterial agent
This invention discloses a formulation for pet oral cleaning and softening of dental plaque and tartar, and its preparation method, belonging to the technical field of pet oral cleaning formulations. The formulation comprises the following components: 0.5%-2.0% complex protease, 0.3%-1.2% repair agent, 0.05%-0.2% antibacterial agent, 0.2%-0.8% probiotic active liquid, 0.03%-0.3% metal chelating agent, 0.1%-2% emulsifier, 5%-15% humectant, 0.01%-0.3% breath freshener, 0.1%-0.5% pH adjuster, and the balance purified water. The complex protease is composed of subtilisin, bromelain, and papain. This invention, through the combination of a multi-enzyme synergistic system and active components, achieves effective removal of pet dental plaque and a significant softening and peeling effect on dental tartar. The resulting formulation is compatible with the pet's oral physiological environment, and long-term use can effectively prevent the occurrence of oral diseases.
Owner:HENAN SURANYIJIA BIOLOGICAL ENGINEERING CO LTD